CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +20,000 | $16.65 | $333K | 787,780 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,283 | $96.85 | $705K | 780,497 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,802 | $97.96 | $470K | 775,695 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,586 | $98.89 | $157K | 774,109 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,897 | $100.10 | $490K | 769,212 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,244 | $101.06 | $126K | 767,968 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −188 | $101.72 | $19K | 767,780 |
| 2026-11-16 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −20,000 | $16.65 | $333K | 211,770 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +1,552 | $18.41 | $29K | 769,332 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +18,448 | $16.65 | $307K | 787,780 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,992 | $100.02 | $799K | 779,788 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −12,008 | $100.61 | $1.2M | 767,780 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −1,552 | $18.41 | $29K | 0 |
| 2026-11-13 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −18,448 | $16.65 | $307K | 231,770 |
| 2026-11-12 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +20,000 | $18.41 | $368K | 787,780 |
| 2026-11-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,711 | $101.09 | $1.1M | 777,069 |
| 2026-11-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,289 | $101.49 | $943K | 767,780 |
| 2026-11-12 | Torley Helen PRESIDENT AND CEO | Exercise or conversion · Option to Purchase Common Stock 10b5-1 | −20,000 | $18.41 | $368K | 1,552 |
| 2026-10-08 | Torley Helen PRESIDENT AND CEO | Exercise or conversion 10b5-1 | +20,000 | $18.41 | $368K | 787,780 |
| 2026-10-08 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,810 | $108.18 | $520K | 782,970 |
Page 1 of 48 · 944 trades